Raw powder / synthesis & purification

Bulk Raw Lyophilized Powder

1g–1kg supply for laboratory research, formulators and B2B repackers. High-purity powder, protected from production to delivery.

Manufacturing process

From amino acids to released lyophilized powder.

  1. 01

    SPPS synthesis

    Stepwise amino-acid coupling on a solid support, followed by cleavage and crude-peptide isolation.

  2. 02

    Preparative HPLC

    Chromatographic purification separates target peptide from process-related impurities; salt exchange sets the counterion specification.

  3. 03

    Lyophilization

    Controlled freezing and vacuum drying remove solvent while preserving a dry porous powder.

  4. 04

    Analytical release

    HPLC purity and MS identity are checked against the agreed batch specifications before barrier packing.

Illustrative 1g sample tube, 10g–50g fluorinated bottles and 100g–1kg foil bags
1g sample tube10g–50g fluorinated bottle100g–1kg foil bag

Illustrative packaging presentation. Final pack specifications confirmed in your quote.

Protected. Traceable. Scalable.

From gram-scale qualification to kilogram supply.

Acetate Salt & TFA-Free Standards

Request compound-specific counterion, residual TFA and analytical acceptance limits. Final specifications are confirmed on the batch COA.

Medical-Grade Aluminium Foil Bags

Vacuum-sealed barrier packaging protects against moisture and light; nitrogen-flushed packing supports lyophilized stability.

High-Purity Research Raw Materials

≥99.2% HPLC release specification for peptide compounds, with batch-specific HPLC/MS documentation and independent blind testing supported.

3-layer discreet packaging

Three barriers between your powder and the outside world.

01 · Inner layer

Anti-Static Sterile Bag

Direct powder contact; static-free and sterile.

02 · Middle layer

Vacuum-Sealed Foil Bag

High-barrier aluminium, vacuum sealed against moisture and light.

03 · Outer layer

Compliant Drum / Box

Plain, shock-proof outer carton or drum for compliant raw-material transit.

Salt form comparison

Acetate Salt vs. TFA-Free

Acetate describes the peptide's counterion. TFA-free describes an agreed residual-trifluoroacetic-acid specification, not a separate peptide identity or an automatic guarantee of absolute zero TFA. An acetate salt can also meet a TFA-free specification.

PropertyAcetate SaltTFA-Free
CounterionAcetateAcetate or HCl, residual TFA limited
AppearanceWhite fluffy lyophilized powderWhite lyophilized powder
Residual TFAReduced via salt exchangeExplicit limit on COA (e.g. ≤0.1%)
Best forGeneral formulation workTFA-sensitive formulations & assays

Typical values; compound-specific limits are confirmed on the batch COA.

Storage & moisture control

01 / Cold storage

−20°C

Keep lyophilized peptide powder sealed, dry and protected from light; follow the compound-specific COA.

02 / Before opening

Equilibrate

Let the unopened pack reach room temperature before opening to reduce condensation.

03 / After sampling

Reseal

Minimize humidity exposure and repeated freeze-thaw cycles. Use suitable laboratory handling procedures.

Packaging and stability are compound-specific. Final storage requirements and shelf life must be confirmed against the supplied batch documentation.

Explore compound-specific specifications.

Browse Catalog to Select Form

Case studies & insights

Related from the RedcoBio blog

All articles →

Inquiry cart is empty